These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9214117)

  • 1. [Aneuploidy and proliferative activity in breast cancer (flow-cytometric investigation)].
    Bychkova NV; Pozharisskiĭ KM
    Vopr Onkol; 1997; 43(2):171-5. PubMed ID: 9214117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological indicators of aggressiveness in T1 ductal invasive breast cancer.
    Bucci B; Carico E; Rinaldi A; Froio F; Puce YM; D'Agnano I; Vecchione A; Brunetti E
    Anticancer Res; 2001; 21(4B):2949-55. PubMed ID: 11712792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AgNORs in ductal breast cancer: correlation with ploidy and S-phase fraction by DNA flow cytometry.
    Borgiani L; Cogorno P; Oliviero J; Toso F; Gambini G; Tunesi G; Canepa M
    Eur J Histochem; 1994; 38(2):171-6. PubMed ID: 7524814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
    Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
    Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas.
    Smith CA; Pollice AA; Gu LP; Brown KA; Singh SG; Janocko LE; Johnson R; Julian T; Hyams D; Wolmark N; Sweeney L; Silverman JF; Shackney SE
    Clin Cancer Res; 2000 Jan; 6(1):112-26. PubMed ID: 10656439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Male breast cancer. Histochemical and flow cytometry analysis of 6 cases].
    Galasso MG; Galia A; Gazzano G; Cosentino A; Castorina S
    Pathologica; 1995 Oct; 87(5):503-5. PubMed ID: 8868175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA analysis of in situ ductal carcinoma of the breast via flow cytometry.
    Ottesen GL; Christensen IJ; Larsen JK; Christiansen J; Hansen B; Andersen JA
    Cytometry; 1995 Sep; 22(3):168-76. PubMed ID: 8556947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometry and quantitative immunohistochemical study of cell cycle regulation proteins in invasive breast carcinoma: prognostic significance.
    Michels JJ; Duigou F; Marnay J; Henry-Amar M; Delozier T; Denoux Y; Chasle J
    Cancer; 2003 Mar; 97(6):1376-86. PubMed ID: 12627500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathology and heredity of breast cancer in younger women.
    Marcus JN; Watson P; Page DL; Lynch HT
    J Natl Cancer Inst Monogr; 1994; (16):23-34. PubMed ID: 7999466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [DNA content analysis of breast cancer cells recognized by monoclonal antibody].
    Zhu LW
    Zhonghua Zhong Liu Za Zhi; 1993 Sep; 15(5):347-50. PubMed ID: 8174478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Male and female breast cancer--differences in DNA ploidy, p21 and p53 expression reinforce the possibility of distinct pathways of oncogenesis.
    André S; Pinto AE; Laranjeira C; Quaresma M; Soares J
    Pathobiology; 2007; 74(6):323-7. PubMed ID: 18087196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Flow-cytometric study of aneuploidy and proliferative activity of endometrial cancer cells as indicators of tumor aggressiveness].
    Bychkova NV; Meshkova IE; Pozharisskiĭ KM
    Vopr Onkol; 1996; 42(2):57-62. PubMed ID: 8815635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric detection of multifocal DNA aneuploid cell populations in mastectomy specimens containing a primary breast carcinoma.
    van Dam PA; Van Bockstaele DR; Keersmaeckers GH; Uyttenbroeck FL
    Cytometry; 1990; 11(2):300-7. PubMed ID: 2318083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of proliferation activity in breast carcinoma by flow cytometry analysis of S-phase and quantitative analysis of MIB-1.
    Masood S; Bui MM; Lu L
    Ann Clin Lab Sci; 1998; 28(6):315-23. PubMed ID: 9846198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of the ploidy and cell proliferation of malignant epithelial neoplasms of various origin (flow cytometric assay)].
    Bychkova NV; Meshkova IE; Pozharisskiĭ KM
    Vopr Onkol; 1998; 44(1):54-9. PubMed ID: 9578732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative DNA analysis of breast cancer by flow cytometry and image analysis.
    Borgiani L; Cogorno P; Toso F; Gallo L; Buccaran G; Rovida S; Canepa M
    Pathologica; 1994 Aug; 86(4):356-9. PubMed ID: 7535909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA proliferative index as a marker in Iraqi aneuploid mammary carcinoma.
    al-Alwan NA
    East Mediterr Health J; 2000; 6(5-6):1062-72. PubMed ID: 12197329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathological and clinical correlations of cystosarcoma phyllodes.
    Murad TM; Hines JR; Beal J; Bauer K
    Arch Pathol Lab Med; 1988 Jul; 112(7):752-6. PubMed ID: 2838007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Her2/neu analysis in formalin-fixed, paraffin-embedded breast carcinomas: comparison of immunohistochemistry and multiparameter DNA flow cytometry.
    Leers MP; Hoop JG; Nap M
    Anticancer Res; 2003; 23(2A):999-1006. PubMed ID: 12820338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.